Foxwell B M, Donovan T A, Thorpe P E, Wilson G
Biochim Biophys Acta. 1985 Jun 18;840(2):193-203. doi: 10.1016/0304-4165(85)90119-9.
Recently, several investigators have explored the possibility of targeting ricin to designated cell types in animals by its linkage to specific antibodies. There is evidence, however, that the mannose-containing oligosaccharide chains on ricin are recognised by reticuloendothelial cells in the liver and spleen and so cause the immunotoxins to be removed rapidly from the blood stream. In the present study we analysed the carbohydrate composition of ricin and examined enzymic methods for removing the carbohydrate. The carbohydrate analysis ricin A-chain revealed the presence of one residue of xylose and one of fucose in addition to mannose and N-acetylglucosamine which had been detected previously. The B-chain contained only mannose and N-acetylglycosamine. Ricin A-chain is heterogeneous containing two components of molecular weight 30 000 and 32 000. Strong evidence was found that the heavier form of the A-chain contains an extra carbohydrate unit which is heterogeneous with respect to concanavalin A binding and sensitivity to endoglycosidase H. The lower molecular weight form of A-chain did not bind concanavalin A and was insusceptible to endoglycosidases. Only one of the two high mannose oligosaccharide units on the isolated B-chain could be removed by endoglycosidases H or F, whereas both were removable after denaturation of the polypeptide by SDS. Both the isolated A- and B-chains were sensitive to alpha-mannosidase. Intact ricin was resistant to endoglycosidase treatment and was only slightly sensitive to alpha-mannosidase. The addition of SDS allowed endoglycosidase H to remove both of the B-chain oligosaccharides from intact ricin and increased the toxin's sensitivity to alpha-mannosidase. In conclusion, extensive enzymic deglycosylation of ricin may only be possible if the A- and B-chains are first separated, treated with enzymes and then recombined to form the toxin.
最近,几位研究人员探讨了通过将蓖麻毒素与特定抗体连接,使其靶向动物体内特定细胞类型的可能性。然而,有证据表明,蓖麻毒素上含甘露糖的寡糖链会被肝脏和脾脏中的网状内皮细胞识别,从而导致免疫毒素迅速从血流中清除。在本研究中,我们分析了蓖麻毒素的碳水化合物组成,并研究了去除碳水化合物的酶法。对蓖麻毒素A链的碳水化合物分析表明,除了先前检测到的甘露糖和N-乙酰葡糖胺外,还存在一个木糖残基和一个岩藻糖残基。B链仅含有甘露糖和N-乙酰葡糖胺。蓖麻毒素A链具有异质性,包含分子量为30000和32000的两个组分。有充分证据表明,较重形式的A链含有一个额外的碳水化合物单元,该单元在伴刀豆球蛋白A结合和对内切糖苷酶H的敏感性方面具有异质性。较低分子量形式的A链不结合伴刀豆球蛋白A,对内切糖苷酶不敏感。分离的B链上的两个高甘露糖寡糖单元中只有一个可以被内切糖苷酶H或F去除,而在通过SDS使多肽变性后,两个单元都可以被去除。分离的A链和B链都对α-甘露糖苷酶敏感。完整的蓖麻毒素对内切糖苷酶处理具有抗性,仅对α-甘露糖苷酶略有敏感。加入SDS可使内切糖苷酶H从完整的蓖麻毒素中去除两个B链寡糖,并增加毒素对α-甘露糖苷酶的敏感性。总之,只有先将蓖麻毒素的A链和B链分离,用酶处理,然后重新组合形成毒素,才可能进行广泛的酶促去糖基化。